Nareen Abboud, Ph.D. - Publications
Affiliations: | 2009 | Yeshiva University, New York, NY, United States |
Area:
Immunology, Microbiology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Bournazos S, Chow SK, Abboud N, Casadevall A, Ravetch JV. Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity. The Journal of Clinical Investigation. 124: 725-9. PMID 24401277 DOI: 10.1172/Jci72676 | 0.688 | |||
2010 | Abboud N, Chow SK, Saylor C, Janda A, Ravetch JV, Scharff MD, Casadevall A. A requirement for FcγR in antibody-mediated bacterial toxin neutralization. The Journal of Experimental Medicine. 207: 2395-405. PMID 20921285 DOI: 10.1084/Jem.20100995 | 0.462 | |||
2009 | Abboud N, De Jesus M, Nakouzi A, Cordero RJ, Pujato M, Fiser A, Rivera J, Casadevall A. Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. The Journal of Biological Chemistry. 284: 25077-86. PMID 19617628 DOI: 10.1074/Jbc.M109.022061 | 0.698 | |||
2008 | Abboud N, Casadevall A. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clinical and Vaccine Immunology : Cvi. 15: 1115-23. PMID 18480236 DOI: 10.1128/Cvi.00015-08 | 0.707 | |||
2006 | Rivera J, Nakouzi A, Abboud N, Revskaya E, Goldman D, Collier RJ, Dadachova E, Casadevall A. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infection and Immunity. 74: 4149-56. PMID 16790789 DOI: 10.1128/Iai.00150-06 | 0.725 | |||
Show low-probability matches. |